# Century Aluminum Co: financial statements, quarterly

CENX · Nasdaq · CIK 949157 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cenx.md) · [Financials](/companies/cenx/financials.md) · [Filings](/companies/cenx/filings.md) · [Insiders](/companies/cenx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cenx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [545](/filings/0000949157-23-000071.md) | [512 d](/filings/0001628280-26-013788.md) | [490](/filings/0000949157-25-000035.md) | [561](/filings/0001628280-25-038882.md) | [539](/filings/0001628280-25-050200.md) | [631 d](/filings/0001628280-26-013788.md) | [634](/filings/0001628280-26-032094.md) | [628](/filings/0001628280-26-054308.md) | [632](/filings/0001628280-25-050200.md) | [634 d](/filings/0001628280-26-013788.md) | [649](/filings/0001628280-26-032094.md) | [752](/filings/0001628280-26-054308.md) |
| Cost of revenue | $m | [557](/filings/0000949157-23-000071.md) | [477 d](/filings/0001628280-26-013788.md) | [477](/filings/0001628280-26-013788.md) | [545](/filings/0001628280-26-013788.md) | [462](/filings/0001628280-26-013788.md) | [578 d](/filings/0001628280-26-013788.md) | [577](/filings/0001628280-26-032094.md) | [595](/filings/0001628280-26-054308.md) | [557](/filings/0001628280-26-013788.md) | [551 d](/filings/0001628280-26-013788.md) | [530](/filings/0001628280-26-032094.md) | [524](/filings/0001628280-26-054308.md) |
| Gross profit | $m | [(11.5)](/filings/0000949157-23-000071.md) | [35.1 d](/filings/0001628280-26-013788.md) | [13.0](/filings/0001628280-26-013788.md) | [15.5](/filings/0001628280-26-013788.md) | [76.9](/filings/0001628280-26-013788.md) | [53.3 d](/filings/0001628280-26-013788.md) | [57.3](/filings/0001628280-26-032094.md) | [33.6](/filings/0001628280-26-054308.md) | [74.9](/filings/0001628280-26-013788.md) | [82.3 d](/filings/0001628280-26-013788.md) | [119](/filings/0001628280-26-032094.md) | [228](/filings/0001628280-26-054308.md) |
| Selling, general and administrative | $m | [10.8](/filings/0000949157-23-000071.md) | [8.1 d](/filings/0001628280-26-013788.md) | [14.1](/filings/0000949157-25-000035.md) | [12.3](/filings/0001628280-25-038882.md) | [15.6](/filings/0001628280-25-050200.md) | [14.8 d](/filings/0001628280-26-013788.md) | [12.5](/filings/0001628280-26-032094.md) | [14.0](/filings/0001628280-26-054308.md) | [17.9](/filings/0001628280-25-050200.md) | [35.5 d](/filings/0001628280-26-013788.md) | [25.8](/filings/0001628280-26-032094.md) | [15.9](/filings/0001628280-26-054308.md) |
| Operating income | $m | [(24.2)](/filings/0000949157-23-000071.md) | [24.9 d](/filings/0001628280-26-013788.md) | [(1.6)](/filings/0001628280-26-013788.md) | [1.5](/filings/0001628280-26-013788.md) | [58.9](/filings/0001628280-26-013788.md) | [36.3 d](/filings/0001628280-26-013788.md) | [42.8](/filings/0001628280-26-032094.md) | [18.1](/filings/0001628280-26-054308.md) | [55.9](/filings/0001628280-26-013788.md) | [33.0 d](/filings/0001628280-26-013788.md) | [374](/filings/0001628280-26-032094.md) | [212](/filings/0001628280-26-054308.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(11.0)](/filings/0000949157-23-000071.md) | [6.6 d](/filings/0001628280-26-013788.md) | [0.5](/filings/0000949157-25-000035.md) | [0.5](/filings/0001628280-25-038882.md) | [2.0](/filings/0001628280-25-050200.md) | [0.2 d](/filings/0001628280-26-013788.md) | [1.6](/filings/0001628280-26-032094.md) | [(1.3)](/filings/0001628280-26-054308.md) | [(1.1)](/filings/0001628280-25-050200.md) | [(12.3) d](/filings/0001628280-26-013788.md) | [1.8](/filings/0001628280-26-032094.md) | [12.1](/filings/0001628280-26-054308.md) |
| Net income | $m | [(42.0)](/filings/0000949157-23-000071.md) | [30.0 d](/filings/0001628280-26-013788.md) | [247](/filings/0001628280-26-013788.md) | [(2.5)](/filings/0001628280-26-013788.md) | [47.3](/filings/0001628280-26-013788.md) | [45.2 d](/filings/0001628280-26-013788.md) | [29.7](/filings/0001628280-26-032094.md) | [(4.6)](/filings/0001628280-26-054308.md) | [14.9](/filings/0001628280-26-013788.md) | [1.8 d](/filings/0001628280-26-013788.md) | [338](/filings/0001628280-26-032094.md) | [249](/filings/0001628280-26-054308.md) |
| Diluted EPS | $ per share | [(0.45)](/filings/0000949157-23-000071.md) | not reported | [2.26](/filings/0000949157-25-000035.md) | [(0.03)](/filings/0001628280-25-038882.md) | [0.46](/filings/0001628280-25-050200.md) | not reported | [0.29](/filings/0001628280-26-032094.md) | [(0.05)](/filings/0001628280-26-054308.md) | [0.15](/filings/0001628280-25-050200.md) | not reported | [3.23](/filings/0001628280-26-032094.md) | [2.39](/filings/0001628280-26-054308.md) |
| Basic EPS | $ per share | [(0.45)](/filings/0000949157-23-000071.md) | not reported | [2.52](/filings/0000949157-25-000035.md) | [(0.03)](/filings/0001628280-25-038882.md) | [0.48](/filings/0001628280-25-050200.md) | not reported | [0.30](/filings/0001628280-26-032094.md) | [(0.05)](/filings/0001628280-26-054308.md) | [0.15](/filings/0001628280-25-050200.md) | not reported | [3.41](/filings/0001628280-26-032094.md) | [2.52](/filings/0001628280-26-054308.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [70.3](/filings/0000949157-23-000071.md) | [88.8](/filings/0001628280-26-013788.md) | [93.5](/filings/0000949157-24-000046.md) | [41.3](/filings/0000949157-24-000078.md) | not reported | [32.9](/filings/0001628280-26-013788.md) | [44.9](/filings/0000949157-25-000035.md) | [40.7](/filings/0001628280-25-038882.md) | [151](/filings/0001628280-25-050200.md) | [134](/filings/0001628280-26-054308.md) | [244](/filings/0001628280-26-032094.md) | [343](/filings/0001628280-26-054308.md) |
| Current assets | $m | [684](/filings/0000949157-23-000071.md) | [767](/filings/0001628280-26-013788.md) | [783](/filings/0001628280-26-013788.md) | [729](/filings/0001628280-26-013788.md) | [804](/filings/0001628280-26-013788.md) | [811](/filings/0001628280-26-013788.md) | [830](/filings/0001628280-26-032094.md) | [807](/filings/0001628280-26-054308.md) | [1,047](/filings/0001628280-26-013788.md) | [1,031](/filings/0001628280-26-054308.md) | [1,255](/filings/0001628280-26-032094.md) | [1,402](/filings/0001628280-26-054308.md) |
| Total assets | $m | [1,761](/filings/0000949157-23-000071.md) | [2,029](/filings/0001628280-26-013788.md) | [2,006](/filings/0001628280-26-013788.md) | [1,958](/filings/0001628280-26-013788.md) | [2,059](/filings/0001628280-26-013788.md) | [2,120](/filings/0001628280-26-013788.md) | [2,133](/filings/0001628280-26-032094.md) | [2,142](/filings/0001628280-26-054308.md) | [2,322](/filings/0001628280-26-013788.md) | [2,269](/filings/0001628280-26-054308.md) | [2,655](/filings/0001628280-26-032094.md) | [2,875](/filings/0001628280-26-054308.md) |
| Current liabilities | $m | [634](/filings/0000949157-23-000071.md) | [764](/filings/0001628280-26-013788.md) | [469](/filings/0000949157-24-000046.md) | [428](/filings/0000949157-24-000078.md) | not reported | [467](/filings/0001628280-26-013788.md) | [444](/filings/0001628280-26-032094.md) | [448](/filings/0001628280-26-054308.md) | [592](/filings/0001628280-26-013788.md) | [524](/filings/0001628280-26-054308.md) | [545](/filings/0001628280-26-032094.md) | [509](/filings/0001628280-26-054308.md) |
| Total liabilities | $m | not reported | [1,502](/filings/0000949157-24-000078.md) | not reported | [1,222](/filings/0000949157-24-000078.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | not reported | [431](/filings/0000949157-24-000028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [84.0](/filings/0000949157-23-000071.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [333](/filings/0000949157-23-000071.md) | [356](/filings/0001628280-26-013788.md) | [602](/filings/0000949157-24-000046.md) | [602](/filings/0000949157-24-000078.md) | [765](/filings/0001628280-26-013788.md) | [694](/filings/0001628280-26-013788.md) | [726](/filings/0000949157-25-000035.md) | [724](/filings/0001628280-25-038882.md) | [742](/filings/0001628280-25-050200.md) | [806](/filings/0001628280-26-054308.md) | [1,151](/filings/0001628280-26-032094.md) | [1,403](/filings/0001628280-26-054308.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [41.5 d](/filings/0000949157-23-000071.md) | [66.0 d](/filings/0001628280-26-013788.md) | [(14.8)](/filings/0000949157-25-000035.md) | [11.5 d](/filings/0001628280-25-038882.md) | [20.1 d](/filings/0001628280-25-050200.md) | [(41.4) d](/filings/0001628280-26-013788.md) | [72.3](/filings/0001628280-26-032094.md) | [7.9 d](/filings/0001628280-26-054308.md) | [2.0 d](/filings/0001628280-25-050200.md) | [103 d](/filings/0001628280-26-013788.md) | [68.4](/filings/0001628280-26-032094.md) | [168 d](/filings/0001628280-26-054308.md) |
| Capital expenditure | $m | [26.1 d](/filings/0000949157-23-000071.md) | [32.3 d](/filings/0001628280-26-013788.md) | [29.7](/filings/0000949157-25-000035.md) | [16.9 d](/filings/0001628280-25-038882.md) | [22.5 d](/filings/0001628280-25-050200.md) | [13.2 d](/filings/0001628280-26-013788.md) | [21.2](/filings/0001628280-26-032094.md) | [23.8 d](/filings/0001628280-26-054308.md) | [20.1 d](/filings/0001628280-25-050200.md) | [35.1 d](/filings/0001628280-26-013788.md) | [74.8](/filings/0001628280-26-032094.md) | [59.6 d](/filings/0001628280-26-054308.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [97.3](/filings/0000949157-23-000071.md) | [92.3](/filings/0000949157-24-000046.md) | [93.2](/filings/0000949157-24-000078.md) | [92.4](/filings/0000949157-23-000071.md) | [98.7](/filings/0000949157-25-000035.md) | [92.7](/filings/0001628280-25-038882.md) | [98.4](/filings/0001628280-25-050200.md) | [99.2](/filings/0001628280-26-032094.md) | [93.3](/filings/0001628280-26-054308.md) | [99.2](/filings/0001628280-25-050200.md) | [105](/filings/0001628280-26-032094.md) | [105](/filings/0001628280-26-054308.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 98,993,295 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054308.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.